Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Therapy reduction in patients with Down syndrome and myeloid leukemia: the international ML-DS 2006 trial

Madita Uffmann, Mareike Rasche, Martin Zimmermann, Christine von Neuhoff, Ursula Creutzig, Michael Dworzak, Lenie Scheffers, Henrik Hasle, C. Michel Zwaan, Dirk Reinhardt, Jan-Henning Klusmann

Blood (2017) 129 (25): 3314–3321.

https://doi.org/10.1182/blood-2017-01-765057

Published: 2017

Includes: Supplemental data

Journal Articles

The Prognostic Impact of Cytogenetics and Karyotype Changes in Pediatric Patients with Relapsed Acute Myeloid Leukemia: A Retrospective Cohort Study within the Relapsed AML 2001/01 Study

Blood (2016) 128 (22): 2896.

https://doi.org/10.1182/blood.V128.22.2896.2896

Published: 2016

Journal Articles

Analysis of WT1 Mutations and Combined Aberrations in Childhood Acute Myeloid Leukemia using Whole Exome Sequencing

Nils von Neuhoff, PhD, Peter Husemann, PhD, Robert Geffers, PhD, Christiane Walter, M.Sc., Christine von Neuhoff, MD, Martin Zimmermann, PhD, Brigitte Schlegelberger, MD, Dirk Reinhardt, MD PhD

Blood (2014) 124 (21): 2340.

https://doi.org/10.1182/blood.V124.21.2340.2340

Published: 2014

Journal Articles

Pediatric Fanconi Anemia With Secondary AML: A Retrospective Outcome Report From The German AML-BFM Group

Rita Beier, MD, Sayed Hoseini, MD, Britta Maecker-Kolhoff, MD, Reinhard Schneppenheim, MD, PhD, Christine von Neuhoff, MD, Wolfram Ebell, MD, Hansjörg Schmid, MD, Peter Bader, Karoline Ehlert, MD, Karl-Walter Sykora, MD, Ursula Creutzig, MD, Christian Kratz, Mwe Mwe Chao, MD, Dirk Reinhardt, Martin G. Sauer, MD

Blood (2013) 122 (21): 1414.

https://doi.org/10.1182/blood.V122.21.1414.1414

Published: 2013

Journal Articles

Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004

Ursula Creutzig, Martin Zimmermann, Jean-Pierre Bourquin, Michael N. Dworzak, Gudrun Fleischhack, Norbert Graf, Thomas Klingebiel, Bernhard Kremens, Thomas Lehrnbecher, Christine von Neuhoff, Jörg Ritter, Annette Sander, André Schrauder, Arend von Stackelberg, Jan Starý, Dirk Reinhardt

Blood (2013) 122 (1): 37–43.

https://doi.org/10.1182/blood-2013-02-484097

Published: 2013

Includes: Supplemental data

Journal Articles

Additional Prognostic Impact of Specific Sites of Extramedullary Leukemia in Pediatric AML with MLL-Rearrangements but Not in Core-Binding Factor (CBF) AML.

Ursula Creutzig, MD, PhD, Martin Zimmermann, PhD, Michael Dworzak, Jean-Pierre Bourquin, MD, PhD, Christine von Neuhoff, MD, Annette Sander, MD, Jan Stary, Dirk Reinhardt, MD

Blood (2012) 120 (21): 2621.

https://doi.org/10.1182/blood.V120.21.2621.2621

Published: 2012

Journal Articles

Transient and Myeloid Leukemia in Children with Down Syndrome Mosaic

Alexandra Kolenova, MD, PhD, Katarina Reinhardt, PhD, Michaela Nathrath, MD, Claudia Rossig, MD, PhD, Arend von Stackelberg, MD, Christine von Neuhoff, MD, Annette Sander, MD, Peter Svec, MD, PhD, C. Michel Zwaan, MD, PhD, Ursula Creutzig, MD, PhD, Dirk Reinhardt, MD, PhD

Blood (2011) 118 (21): 2539.

https://doi.org/10.1182/blood.V118.21.2539.2539

Published: 2011

Journal Articles

Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16)

Ursula Creutzig, Martin Zimmermann, Jean-Pierre Bourquin, Michael N. Dworzak, Christine von Neuhoff, Annette Sander, André Schrauder, Andrea Teigler-Schlegel, Jan Starý, Selim Corbacioglu, Dirk Reinhardt

Blood (2011) 118 (20): 5409–5415.

https://doi.org/10.1182/blood-2011-07-364661

Published: 2011

Includes: Supplemental data

Journal Articles

Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia

Kate A. Alford, Katarina Reinhardt, Catherine Garnett, Alice Norton, Katarina Böhmer, Christine von Neuhoff, Alexandra Kolenova, Emanuele Marchi, Jan-Henning Klusmann, Irene Roberts, Henrik Hasle, Dirk Reinhardt, Paresh Vyas

Blood (2011) 118 (8): 2222–2238.

https://doi.org/10.1182/blood-2011-03-342774

Published: 2011

Includes: Supplemental data

Journal Articles

New Aspects for Future Stratifications In Paediatric AML: Outcome According to Cytogenetics of 386 Patients Enrolled In Study AML-BFM 2004

Christine von Neuhoff, MD, Annette Sander, MD, Jutta Bradtke, PhD, Silja Roettgers, PhD, Andrea Teigler-Schlegel, PhD, Martin Zimmermann, PhD, Johanna Ohlendorf, Nils von Neuhoff, PhD, Ursula Creutzig, MD, Dirk Reinhardt, MD, PhD

Blood (2010) 116 (21): 2741.

https://doi.org/10.1182/blood.V116.21.2741.2741

Published: 2010

Journal Articles

Is Prevention of Myeloid Leukemia Possible?.

Katarina Reinhardt, Marjolein Blink, MD, Annette Sander, Christine von Neuhoff, Katarina Boehmer, Alexandra Kolenova, Jan Stary, Denisa Mendelova, Jan-Henning Klusmann, MD, Dominik Schneider, Valerie de Haas, MD, PhD, Claudia Rossig, MD, Marry M. van den Heuvel, MD, PhD, Ursula Creutzig, MD, C. Michel Zwaan, MD, PhD, Dirk Reinhardt, MD, PhD

Blood (2009) 114 (22): 481.

https://doi.org/10.1182/blood.V114.22.481.481

Published: 2009

Journal Articles

Distribution and Outcome According to Cytogenetics in 502 Paediatric AML Patients Treated in Study AML-BFM 98.

Christine von Neuhoff, MD, Jutta Bradtke, Martin Zimmermann, PhD, Jean-Pierre Bourquin, MD, PhD, David Betts, BSc, Jan Stary, MD, PhD, Zuzana Zemanova, MD, Michael N Dworzak, MD, PhD, Dirk Reinhardt, MD, PhD, U. Creutzig

Blood (2008) 112 (11): 1510.

https://doi.org/10.1182/blood.V112.11.1510.1510

Published: 2008

Journal Articles

GATA1 Mutations in Transient Leukemia and Myeloid Leukemia in “Down” Syndrome.

Katarina Reinhardt, PhD, Katarina Boehmer, Jan-Henning Klusmann, MD, Manuela Germeshausen, PhD, Annette Sander, MD, Christine von Neuhoff, MD, Jan Stary, MD, PhD, Heribert Jürgens, MD, PhD, Arnulf Pekrun, MD, PhD, Axel Sauerbrey, MD, PhD, Charlotte M Niemeyer, MD, PhD, Gudrun Fleischhack, MD, PhD, Ursula Creutzig, MD, PhD, Dirk Reinhardt, MD, PhD

Blood (2008) 112 (11): 923.

https://doi.org/10.1182/blood.V112.11.923.923

Published: 2008

NARROW

Therapy reduction in patients with Down syndrome and myeloid leukemia: the international ML-DS 2006 trial

The Prognostic Impact of Cytogenetics and Karyotype Changes in Pediatric Patients with Relapsed Acute Myeloid Leukemia: A Retrospective Cohort Study within the Relapsed AML 2001/01 Study

Analysis of WT1 Mutations and Combined Aberrations in Childhood Acute Myeloid Leukemia using Whole Exome Sequencing

Pediatric Fanconi Anemia With Secondary AML: A Retrospective Outcome Report From The German AML-BFM Group

Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004

Additional Prognostic Impact of Specific Sites of Extramedullary Leukemia in Pediatric AML with MLL-Rearrangements but Not in Core-Binding Factor (CBF) AML.

Transient and Myeloid Leukemia in Children with Down Syndrome Mosaic

Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16)

Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia

New Aspects for Future Stratifications In Paediatric AML: Outcome According to Cytogenetics of 386 Patients Enrolled In Study AML-BFM 2004

Is Prevention of Myeloid Leukemia Possible?.

Distribution and Outcome According to Cytogenetics in 502 Paediatric AML Patients Treated in Study AML-BFM 98.

GATA1 Mutations in Transient Leukemia and Myeloid Leukemia in “Down” Syndrome.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only